Previous studies report that cerebral ischemia models indicate that NF-κB’s actions are widely harmful and that animals treated with a pharmacological NF-κB inhibition exhibit efficient anti-inflammatory effects [44, 45]. This evidence concerns the gene NFKB1 and Cerebral ischemia.